Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD16-positive, CD56-dim natural killer cell, human | 6 studies | 18% ± 1% | |
regulatory T cell | 5 studies | 16% ± 1% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
CD8-positive, alpha-beta T cell | 4 studies | 17% ± 1% | |
mucosal invariant T cell | 4 studies | 17% ± 1% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 17% ± 2% | |
gamma-delta T cell | 4 studies | 19% ± 3% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 18% ± 2% | |
natural killer cell | 3 studies | 17% ± 1% | |
GABAergic neuron | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of ERCC5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 131.89 | 359 / 359 | 70% | 1.26 | 200 / 286 |
esophagus | 100% | 147.20 | 1443 / 1445 | 68% | 1.16 | 125 / 183 |
intestine | 100% | 180.64 | 966 / 966 | 60% | 1.04 | 314 / 527 |
pancreas | 100% | 122.12 | 328 / 328 | 59% | 0.88 | 105 / 178 |
kidney | 100% | 115.38 | 89 / 89 | 52% | 0.94 | 472 / 901 |
breast | 100% | 181.85 | 459 / 459 | 47% | 0.72 | 526 / 1118 |
thymus | 100% | 210.21 | 653 / 653 | 46% | 0.68 | 279 / 605 |
skin | 100% | 206.06 | 1807 / 1809 | 42% | 0.62 | 199 / 472 |
prostate | 100% | 165.33 | 245 / 245 | 40% | 0.55 | 203 / 502 |
bladder | 100% | 149.43 | 21 / 21 | 38% | 0.63 | 190 / 504 |
brain | 94% | 84.82 | 2483 / 2642 | 43% | 0.64 | 302 / 705 |
lung | 100% | 177.15 | 578 / 578 | 36% | 0.57 | 414 / 1155 |
uterus | 100% | 170.63 | 170 / 170 | 30% | 0.42 | 136 / 459 |
adrenal gland | 100% | 166.81 | 258 / 258 | 26% | 0.36 | 60 / 230 |
ovary | 100% | 202.48 | 180 / 180 | 18% | 0.25 | 78 / 430 |
liver | 100% | 115.60 | 226 / 226 | 11% | 0.18 | 44 / 406 |
adipose | 100% | 178.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 247.42 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 133.99 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 85.73 | 795 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 80.60 | 817 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 122.04 | 764 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 1.12 | 16 / 29 |
tonsil | 0% | 0 | 0 / 0 | 29% | 0.44 | 13 / 45 |
eye | 0% | 0 | 0 / 0 | 24% | 0.32 | 19 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006289 | Biological process | nucleotide-excision repair |
GO_0006285 | Biological process | base-excision repair, AP site formation |
GO_0010225 | Biological process | response to UV-C |
GO_0009411 | Biological process | response to UV |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0006283 | Biological process | transcription-coupled nucleotide-excision repair |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000109 | Cellular component | nucleotide-excision repair complex |
GO_0005662 | Cellular component | DNA replication factor A complex |
GO_0005634 | Cellular component | nucleus |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004519 | Molecular function | endonuclease activity |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0000405 | Molecular function | bubble DNA binding |
GO_0000993 | Molecular function | RNA polymerase II complex binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0004520 | Molecular function | DNA endonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | ERCC5 |
Protein name | Excision repair cross-complementing rodent repair deficiency, complementation group 5 (Xeroderma pigmentosum, complementation group G (Cockayne syndrome)), isoform CRA_b (Xeroderma pigmentosum complementation group G protein splice variant) ERCC excision repair 5, endonuclease ERCC excision repair 5, endonuclease (ERCC5-201 protein) DNA excision repair protein ERCC-5 (EC 3.1.-.-) (DNA repair protein complementing XP-G cells) (Xeroderma pigmentosum group G-complementing protein) |
Synonyms | XPGC ERCM2 XPG ERCC5-201 hCG_29785 |
Description | FUNCTION: Single-stranded structure-specific DNA endonuclease involved in DNA excision repair . Makes the 3'incision in DNA nucleotide excision repair (NER) . Binds and bends DNA repair bubble substrate and breaks base stacking at the single-strand/double-strand DNA junction of the DNA bubble . Plays a role in base excision repair (BER) by promoting the binding of DNA glycosylase NTHL1 to its substrate and increasing NTHL1 catalytic activity that removes oxidized pyrimidines from DNA . Involved in transcription-coupled nucleotide excision repair (TCR) which allows RNA polymerase II-blocking lesions to be rapidly removed from the transcribed strand of active genes . Functions during the initial step of TCR in cooperation with ERCC6/CSB to recognized stalled RNA polymerase II . Also, stimulates ERCC6/CSB binding to the DNA repair bubble and ERCC6/CSB ATPase activity . Required for DNA replication fork maintenance and preservation of genomic stability . Involved in homologous recombination repair (HRR) induced by DNA replication stress by recruiting RAD51, BRCA2, and PALB2 to the damaged DNA site . During HRR, binds to the replication fork with high specificity and stabilizes it . Also, acts upstream of HRR, to promote the release of BRCA1 from DNA . . |
Accessions | A0A494C113 ENST00000652613.1 F2Z2A1 A0A494C0S2 ENST00000651002.1 ENST00000652225.2 [P28715-1] Q9NR54 ENST00000472151.1 A0A090HNM7 P28715 ENST00000651470.1 |